Acute ischemic stroke treatment in a nutshell

More documents

Recommendations

Info

Acute ischaemic stroke treatment strategies Limit damage from incident stroke Reperfusion Antithrombotic BP & glucose control Prevent and manage complications Stroke Units Specific complications
REPERFUSION TIME IS BRAIN An estimated 1.2 billion brain cells, including 58 million neurons, die for each hour that an average stroke goes untreated. (Jeff Saver, ULCA)
Page 1: Acute ischemic stroke treatment in
Page 5 and 6: Reperfusion of salvageable tissue
Page 7 and 8: Improved neurological & functional
Page 9 and 10: Acute intravenous alteplase
Page 11 and 12: • BENEFIT RCT EVIDENCE
Page 13 and 14: TIME IS BRAIN • At 3 months, OR f
Page 15 and 16: Antithrombotic therapy: Antiplatele
Page 17 and 18: Stroke Unit Management • What is
Page 19 and 20: Acute ischaemic stroke treatment st
Page 21 and 22: Antithrombotic agents • Antiplate
Page 23 and 24: Antiplatelets in long-term secondar
Page 25 and 26: Which antiplatelet Acceptable optio
Page 27 and 28: Which antiplatelet better-Combinati
Page 29 and 30: Cilostazol (CSPS II) • Randomised
Page 31 and 32: Anticoagulation in long-term second
Page 33 and 34: Anticoagulants Dosing Monitoring SE
Page 35 and 36: WARFARIN Secondary prevention: Prio
Page 37 and 38: DABIGATRAN AF + high risk for embol
Page 39 and 40: RIVAROXABAN AF + high risk for embo
Page 41 and 42: APIXABAN AF patients could not tole
Page 43 and 44: Other indications for anticoagulati
Page 45 and 46: Good Side: Beneficial Effects • R
Page 47 and 48: One of many concerns Don’t forget
Page 49 and 50: Great population benefit in view of
Page 51 and 52: Management of Hypertension, Diabete
Page 53 and 54:
Should all post-stroke patients be
Page 55 and 56:
Should all post-stroke patients be
Page 57 and 58:
Which antihypertensives to use Law,
Page 59 and 60:
Which antihypertensive to use - Com
Page 61 and 62:
Which antihypertensive to use - Com
Page 63 and 64:
What is the target BP - Upper limit
Page 65 and 66:
What is the target BP - Lower limit
Page 67 and 68:
Diabetes • Diabetes is a risk fac
Page 69 and 70:
Why DM control in stroke patients 4
Page 71 and 72:
How tight should glycemic control b
Page 73 and 74:
How tight should glycemic control b
Page 75 and 76:
Dyslipidemia • Modest relationshi
Page 77 and 78:
Statins and ischemic stroke - Meta-
Page 79 and 80:
Should all stroke patients be on st
Page 81 and 82:
BP control in secondary stroke prev
Page 83 and 84:
Lipid control in secondary stroke p
show all

Acute ischemic stroke treatment in a nutshell

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?